Primary Sclerosing Cholangitis clinical trials at UC Davis

4 in progress, 1 open to eligible people

Showing trials for

  • Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

    open to eligible people ages 18-75

    Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.

    Sacramento, California and other locations

  • Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    Sorry, in progress, not accepting new patients

    The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

    Sacramento, California and other locations

  • Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.

    Sorry, in progress, not accepting new patients

    This study will evaluate the effects of elafibranor (the study drug) in participants with Primary Sclerosing Cholangitis (PSC). PSC is a rare disease of the liver that leads to injury and destruction of bile ducts. Damage to bile ducts leads to buildup of bile in the liver, which then causes further damage, and leads to disease progression. This study will compare elafibranor to a placebo, a dummy treatment. The main objective of the trial will be to study the safety and side effects of the study drug. The trial will also study the study drug's effects on blood tests and other tests related to PSC disease activity.

    Sacramento, California and other locations

  • LB-P8 in Patients With PSC

    Sorry, not currently recruiting here

    The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.

    Sacramento, California and other locations

Our lead scientists for Primary Sclerosing Cholangitis research studies include .

Last updated: